Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$194.69 - $268.46 $19,858 - $27,382
-102 Reduced 59.65%
69 $18,000
Q2 2022

Jul 18, 2022

SELL
$187.54 - $223.02 $174,599 - $207,631
-931 Reduced 84.48%
171 $35,000
Q1 2022

Apr 25, 2022

SELL
$193.77 - $244.14 $528,604 - $666,013
-2,728 Reduced 71.23%
1,102 $232,000
Q4 2021

Jan 24, 2022

SELL
$223.92 - $287.77 $354,465 - $455,539
-1,583 Reduced 29.24%
3,830 $919,000
Q3 2021

Oct 27, 2021

SELL
$282.99 - $369.05 $336,758 - $439,169
-1,190 Reduced 18.02%
5,413 $1.53 Million
Q2 2021

Jul 26, 2021

SELL
$259.0 - $414.71 $1.72 Million - $2.76 Million
-6,651 Reduced 50.18%
6,603 $2.29 Million
Q1 2021

Apr 26, 2021

BUY
$242.95 - $284.63 $10,203 - $11,954
42 Added 0.32%
13,254 $3.71 Million
Q4 2020

Jan 26, 2021

SELL
$236.26 - $355.63 $62,372 - $93,886
-264 Reduced 1.96%
13,212 $3.24 Million
Q3 2020

Oct 16, 2020

BUY
$264.77 - $305.71 $171,570 - $198,100
648 Added 5.05%
13,476 $3.82 Million
Q2 2020

Jul 22, 2020

SELL
$258.66 - $342.55 $113,293 - $150,036
-438 Reduced 3.3%
12,828 $3.43 Million
Q1 2020

Apr 20, 2020

BUY
$268.85 - $341.04 $6,990 - $8,867
26 Added 0.2%
13,266 $4.2 Million
Q4 2019

Jan 17, 2020

SELL
$220.06 - $304.07 $52,154 - $72,064
-237 Reduced 1.76%
13,240 $3.93 Million
Q3 2019

Oct 23, 2019

BUY
$217.44 - $243.88 $72,842 - $81,699
335 Added 2.55%
13,477 $3.14 Million
Q2 2019

Jul 22, 2019

BUY
$219.29 - $241.72 $620,371 - $683,825
2,829 Added 27.43%
13,142 $3.07 Million
Q1 2019

Apr 24, 2019

BUY
$216.71 - $338.96 $647,962 - $1.01 Million
2,990 Added 40.83%
10,313 $2.44 Million
Q4 2018

Jan 23, 2019

SELL
$278.5 - $352.75 $4,177 - $5,291
-15 Reduced 0.2%
7,323 $2.2 Million
Q3 2018

Oct 22, 2018

SELL
$293.51 - $383.83 $108,892 - $142,400
-371 Reduced 4.81%
7,338 $2.59 Million
Q2 2018

Jul 24, 2018

BUY
$257.52 - $306.91 $758,396 - $903,849
2,945 Added 61.82%
7,709 $2.24 Million
Q1 2018

Apr 23, 2018

BUY
$260.13 - $367.91 $1.24 Million - $1.75 Million
4,764 New
4,764 $1.3 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.